Publication  in Reviews in Cardiovascular Medicine,  Neath S-X et al. “The Current and Future Landscape of Urinary Thromboxane Testing to Evaluate Atherothrombotic Risk”. 2014, 15:2; 119-130. “….testing UTxB2 levels is an appropriate first step for identifying individuals at increased risk for downstream atherothrombotic events associated with cardiovascular disease.”